Fundraising Fox

Nanobots Therapeutics

2 known investors

Nanobots Therapeutics develops the MotionTx platform to create nanobots that penetrate tissues and enhance drug accumulation in target cells for therapeutic applications. The company is a spin-off of ICREA and IBEC resulting from research by Prof. Samuel Sánchez.

BiotechDeep TechMedical Devices

Founders & leadership

SS
Samuel SánchezinFounder

Investors · 2

BStartup
Capital CellBarcelona

Funding

SEC filings, press & company announcements
  • Undisclosed amountPre-Seed funding roundSep 2023

    BStartup Health (lead), ACCIÓ StartUp Capital program, ESADE-BAN, Prous Institute for Biomedical Research

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000 - Institute for Bioengineering of Cataloniaibecbarcelona.eu · Sep 2023Nanobots Therapeutics Funding | Complete Analysis | Extruct AIextruct.ai

Frequently asked questions

What does Nanobots Therapeutics do?
Nanobots Therapeutics develops the MotionTx platform to create nanobots that penetrate tissues and enhance drug accumulation in target cells for therapeutic applications. The company is a spin-off of ICREA and IBEC resulting from research by Prof. Samuel Sánchez.
Who founded Nanobots Therapeutics?
Nanobots Therapeutics was founded by Samuel Sánchez.
Who are Nanobots Therapeutics's investors?
Nanobots Therapeutics's investors include BStartup, Capital Cell.